Shell Asset Management Co. Has $462,000 Stake in Encompass Health Corporation $EHC

Shell Asset Management Co. reduced its stake in shares of Encompass Health Corporation (NYSE:EHC) by 56.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,638 shares of the company’s stock after selling 4,639 shares during the quarter. Shell Asset Management Co.’s holdings in Encompass Health were worth $462,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Citizens National Bank Trust Department acquired a new stake in shares of Encompass Health during the 3rd quarter worth about $26,000. First Horizon Corp acquired a new stake in shares of Encompass Health during the third quarter worth approximately $34,000. Westside Investment Management Inc. increased its holdings in shares of Encompass Health by 56.7% during the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after buying an additional 101 shares in the last quarter. Assetmark Inc. boosted its holdings in shares of Encompass Health by 88.1% in the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after acquiring an additional 140 shares in the last quarter. Finally, Root Financial Partners LLC bought a new stake in Encompass Health during the 3rd quarter worth approximately $39,000. 97.25% of the stock is owned by institutional investors.

Encompass Health Trading Down 0.6%

Shares of NYSE EHC opened at $109.43 on Wednesday. Encompass Health Corporation has a fifty-two week low of $92.53 and a fifty-two week high of $127.99. The firm has a market capitalization of $11.01 billion, a P/E ratio of 19.75, a P/E/G ratio of 2.10 and a beta of 0.73. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.08 and a quick ratio of 1.14. The company’s 50 day simple moving average is $103.92 and its 200 day simple moving average is $114.57.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 5th. The company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.29 by $0.17. The company had revenue of $3.09 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The business’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. On average, analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Analyst Ratings Changes

A number of research firms have commented on EHC. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Barclays lifted their price target on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a report on Friday, February 6th. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Finally, Zacks Research lowered shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $143.29.

Insiders Place Their Bets

In other news, CEO Mark J. Tarr sold 150,000 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the completion of the transaction, the chief executive officer directly owned 377,070 shares in the company, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.10% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.